Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence

Drug and Alcohol Dependence

Volumn 85, Issue 3, 2006, Pages 177-184

  Heinzerling, Keith G ^a,b   Shoptaw, Steven ^a,b   Peck, James A ^a   Yang, Xiaowei ^a   Liu, Juanmei ^a   Roll, John ^a   Ling, Walter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Baclofen; Gabapentin; Methamphetamine dependence; Randomized clinical trial

Indexed keywords

BACLOFEN; GABAPENTIN; METHAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; EVALUATION; FEMALE; GABAERGIC SYSTEM; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; NOSE CONGESTION; PAIN; PATIENT COMPLIANCE; PATIENT COUNSELING; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TOOTH PAIN; TREATMENT DURATION; URINALYSIS;

ADULT; AMINES; ANTI-ANXIETY AGENTS; BACLOFEN; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLOHEXANECARBOXYLIC ACIDS; DEMOGRAPHY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; METHAMPHETAMINE; PSYCHOLOGY; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 33749498310     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.03.019     Document Type: Article

References (45)

1. Allison P.D., and SAS Institute. Survival Analysis Using the SAS System: A Practical Guide (1995), SAS Institute, Cary, NC
2. Batki S.L., Moon J., Bradley M., Hersh D., Smolar S., Mengis M., Delucchi K., Sexe D., Bennett S., Lefkowitz E., Chu W., Morello L., Jacob III P., and Jones R.T. Fluoxetine in methamphetamine dependence-a controlled trial: preliminary analysis. The 61st Annual Scientific Meeting of the College on Problems of Drug Dependence. Acapulco, Mexico (1999)
3. Batki S., Moon J., Delucchi K., Hersh D., Bradley M., Aguillon-Doms C., Mendelson J., Jones R., Panganiban T., Everhart T., Mengis M., Smolar S., Helmke H., and Jacob III P. Amlodipine treatment of methamphetamine dependence, a controlled outpatient trial: preliminary analysis. The 63rd Annual Scientific Meeting of the College on Problems of Drug Dependence. Scottsdale, AZ (2001)
4. Beck A. Depression (1967), University of Pennsylvania Press, Philadelphia, PA
5. Berger S.P., Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Leiderman D.B., Montgomery M.A., Goldsmith R.J., Bloch D.A., Singal B.M., and Elkashef A. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 100 Suppl. 1 (2005) 58-67
6. Bisaga A., Aharonovich E., Garawi F., Levin F.R., Rubin E., Raby W.N., and Nunes E.V. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend. 81 (2006) 267-274
7. Brebner K., Phelan R., and Roberts D.C. Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology (Berl.) 148 (2000) 314-321
8. Brebner K., Phelan R., and Roberts D.C. Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol. Biochem. Behav. 66 (2000) 857-862
9. Brebner K., Ahn S., and Phillips A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology (Berl.) 177 (2005) 409-417
10. Brodie J.D., Figueroa E., and Dewey S.L. Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse 50 (2003) 261-265
11. Brodie J.D., Figueroa E., Laska E.M., and Dewey S.L. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55 (2005) 122-125
12. Center for Substance Abuse Research-CESAR, 2005. Methamphetamine Treatment Admission Rates Higher Than Those of Cocaine and/or Heroin in Western States. CESAR Fax 14.
13. Cook C.E., Jeffcoat A.R., Hill J.M., Pugh D.E., Patetta P.K., Sadler B.M., White W.R., and Perez-Reyes M. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metabol. Dispos. 21 (1993) 717-723
14. Cousins M.S., Roberts D.C., and de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend. 65 (2002) 209-220
15. Dewey S.L., Morgan A.E., Ashby Jr. C.R., Horan B., Kushner S.A., Logan J., Volkow N.D., Fowler J.S., Gardner E.L., and Brodie J.D. A novel strategy for the treatment of cocaine addiction. Synapse 30 (1998) 119-129
16. Galloway G.P., Newmeyer J., Knapp T., Stalcup S.A., and Smith D. A controlled trial of imipramine for the treatment of methamphetamine dependence. J. Subst. Abuse Treat. 13 (1996) 493-497
17. Gonzalez G., Sevarino K., Sofuoglu M., Poling J., Oliveto A., Gonsai K., George T.P., and Kosten T.R. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98 (2003) 1625-1632
18. Haney M., Hart C., Collins E.D., and Foltin R.W. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend. 80 (2005) 53-61
19. Haney M., Harta C., Collinsa E., and Foltina R. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend. 80 (2005) 53-61
20. Itzhak Y., and Martin J.L. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology (Berl.) 151 (2000) 226-233
21. Johnson B., Rawson R., Elkashef A., Smith E., Campbell J., Haning W., Carlton B., Mawhinney J., Donovick R., and Weis D. Ondansetron for the treatment of methamphetamine dependence. The 66th Annual Scientific Meeting of the College on Problems of Drug Dependence. San Juan, PR (2004)
22. Kampman K.M., Pettinati H., Lynch K.G., Dackis C., Sparkman T., Weigley C., and O'Brien C.P. A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 75 (2004) 233-240
23. Kelly K.M. Gabapentin. Antiepileptic mechanism of action. Neuropsychobiology 38 (1998) 139-144
24. Li S.M., Yin L.L., Ren Y.H., Pan L.S., and Zheng J.W. GABA(B) receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preference in rats. Life Sci. 70 (2001) 349-356
25. Ling W., Shoptaw S., Wesson D., Rawson R.A., Compton M., and Klett C.J. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res. Monogr. 175 (1997) 208-220
26. Longshore, D., Urada, D., Evans, E., Hser, Y., Prendergast, M., Hawken, A., Bunch, T., Ettner, S., 2004. Evaluation of the Substance Abuse and Crime Prevention Act: 2003 Report. California Health and Human Services Agency, Sacramento, CA.
27. Maneuf Y.P., Gonzalez M.I., Sutton K.S., Chung F.Z., Pinnock R.D., and Lee K. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol. Life Sci. 60 (2003) 742-750
28. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat 9 (1992) 199-213
29. National Association of Counties, 2005. The Meth Epidemic in America. National Association of Counties, Washington, DC.
30. Ranaldi R., and Poeggel K. Baclofen decreases methamphetamine self-administration in rats. Neuroreport 13 (2002) 1107-1110
31. Rawson R.A., Marinelli-Casey P., Anglin M.D., Dickow A., Frazier Y., Gallagher C., Galloway G.P., Herrell J., Huber A., McCann M.J., Obert J., Pennell S., Reiber C., Vandersloot D., and Zweben J. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99 (2004) 708-717
32. Rawson R.A., McCann M.J., Flammino F., Shoptaw S., Miotto K., Reiber C., and Ling W. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 101 (2006) 267-274
33. Roberts D.C., and Brebner K. GABA modulation of cocaine self-administration. Ann. N.Y. Acad. Sci. 909 (2000) 145-158
34. SAS Institute Incorporated. SAS for Windows (Version 9.1.3) (2004), SAS Institute Incorporated, Cary, NC
35. Shoptaw S., Yang X., Rotheram-Fuller E.J., Hsieh Y.C., Kintaudi P.C., Charuvastra V.C., and Ling W. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J. Clin. Psychiatry 64 (2003) 1440-1448
36. Shoptaw S., Reback C.J., Peck J.A., Yang X., Rotheram-Fuller E., Larkins S., Veniegas R.C., Freese T.E., and Hucks-Ortiz C. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 78 (2005) 125-134
37. Shoptaw, S., Huber, A., Peck, J., Yang, X., Liu, J., Dang, J., Roll, J., Shapiro, B., Rotheram-Fuller, E., Ling, W., 2006. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend., in press
38. Singer J. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J. Educ. Behav. Stat. 23 (1998) 323-355
39. Spitzer R., Williams J., Gibbbon M., and First M. The Structured Clinical Interview for DSM-IV (1995), American Psychiatric Press, Washington, DC
40. SPSS Incorporated. SPSS for Windows (Version 12.0.2) (2004), SPSS Incorporated, New York
41. Tabachnick B.G., and Fidell L.S. Using Multivariate Statistics (2000), Allyn and Bacon, Boston, MA
42. United Nations Office on Drugs and Crime, 2004. World Drug Report. United Nations, Geneva, Switzerland.
43. Weerts E.M., Froestl W., and Griffiths R.R. Effects of GABAergic modulators on food and cocaine self-administration in baboons. Drug Alcohol Depend. 80 (2005) 369-376
44. Wuis E.W., Dirks M.J., Termond E.F., Vree T.B., and Van der Kleijn E. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur. J. Clin. Pharmacol. 37 (1989) 181-184
45. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130